The Medicines Company Is A Top Pick For 2017 By: Benzinga via Benzinga January 06, 2017 at 08:45 AM EST Following the impressive phase II ORION-1 results for the RNAi drug, inclisiran (a PCSK9 inhibitor for hypercholesterolemia), ... Read More >> Related Stocks: Alnylam Pharmaceuticals Amgen Medicines Company